golidocitinib
dizal pharmaceuticals
['golidocitinib', 'ptcl', 'lymsm']
golidocitinib in rr ptcl #lymsm showing orr 43% cr25% with tolerable safety profile #asco23
An associate member @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.